Skip to main navigation menu Skip to main content Skip to site footer

Vol. 13 No. 02 (2026)
International Multidisciplinary Journal for Research & Development

Articles

POLYCYSTIC OVARY SYNDROME (PCOS): MODERN DIAGNOSTIC APPROACHES AND TREATMENT STRATEGIES BASED ON INDIVIDUALIZED CARE

Published 2026-02-03

  • Tolasheva Jasminahon Jurabek kizi

Tolasheva Jasminahon Jurabek kizi
Kokand University, Andijan Branch, Faculty of Medicine 2nd-year student of the “General Medicine” program, Group 24-19

Abstract

Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age, characterized by hormonal imbalance, ovulatory dysfunction, and metabolic abnormalities. This study focuses on modern diagnostic methods and individualized treatment strategies for PCOS, emphasizing a patient-centered approach to improve reproductive, metabolic, and psychological outcomes. Early diagnosis and personalized therapy, including lifestyle modifications, pharmacological interventions, and fertility management, play a critical role in reducing complications and enhancing quality of life [1, 2]

 

Keywords

Polycystic Ovary Syndrome, PCOS, diagnosis, individualized treatment, reproductive health, metabolic disorders.

PDF

References

  1. Teede HJ, et al. Polycystic ovary syndrome: Pathophysiology, diagnosis, and treatment. Lancet. 2010; 375(9719): 1942–1958.
  2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS. Fertil Steril. 2004; 81: 19–25.
  3. Azziz R, et al. Clinical review: Epidemiology, diagnosis, and management of PCOS. J Clin Endocrinol Metab. 2005; 90: 1213–1224.
  4. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. Endocr Rev. 2012; 33: 981–1030.
  5. Teede H, et al. International PCOS guideline: 2023 update. Hum Reprod. 2023; 38: 2037–2058.
  6. Ibáñez L, et al. Early intervention in PCOS: Strategies for prevention. Nat Rev Endocrinol. 2017; 13: 184–198.
  7. Balen AH, et al. Ultrasound assessment of polycystic ovaries: Consensus definitions. Hum Reprod Update. 2003; 9: 505–514.
  8. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995; 333: 853–861.
  9. Legro RS, et al. Ovulation induction in women with PCOS. N Engl J Med. 2007; 356: 551–566.
  10. Moran LJ, et al. Lifestyle changes in PCOS: Impact on metabolic and reproductive outcomes. Clin Endocrinol. 2013; 78: 580–587.
  11. Viteri OA, et al. Statistical approaches in clinical endocrinology research. Endocr Pract. 2018; 24: 1137–1147.
  12. Lizneva D, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016; 106: 6–15.
  13. Azziz R, et al. Androgen excess in women: Diagnosis and management. Lancet Diabetes Endocrinol. 2016; 4: 903–918.
  14. Norman RJ, et al. Insulin resistance in PCOS: Pathophysiology and clinical implications. Endocr Rev. 2007; 28: 774–800.
  15. Dokras A. Emotional and psychological burden of PCOS: Current perspectives. Int J Womens Health. 2012; 4: 463–471.

Downloads

Download data is not yet available.